Clinical trial
A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
NCT00157118 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
- Lead sponsor
- Baxalta now part of Shire
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 22, 2003
- Completion date
- March 17, 2005
- Enrollment
- 18 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.